| Type: | combo |
| Component1: | Hydrocodone |
| Class1: | Opioid agonist |
| Component2: | Homatropine |
| Class2: | Muscarinic antagonist |
| Tradename: | Tussigon, Hycodan, Hydromet, others |
| Dailymedid: | Hydrocodone and homatropine |
| Routes Of Administration: | By mouth |
| Atc Prefix: | None |
| Legal Us: | Schedule II |
| Legal Us Comment: | [1] [2] |
| Cas Number: | 8013-91-0 |
| Kegg: | D11076 |
Hydrocodone/homatropine, sold under the brand name Tussigon among others, is a fixed-dose combination medication used for the treatment of cough. It contains hydrocodone, as the bitartrate, an opioid agonist; and homatropine, as the methylbromide, a muscarinic antagonist. It is taken by mouth.
Hydrocodone/homatropine was approved for medical use in the United States in 1943.
In the US, the label for hydrocodone/homatropine contains a black box warning about addiction, abuse, and misuse.